1. R.D. Safian and S.C. Textor, Renal-artery stenosis. N Engl J Med 344 (2001), pp. 431–442.
2. C.J. Tegtmeyer, J. Elson, T.A. Glass et al. , Percutaneous transluminal angioplasty: The treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Radiology 143 (1982), pp. 631–637.
3. C. Haller, Arteriosclerotic renal artery stenosis: Conservative versus interventional management. Heart 88 (2002), pp. 193–197.
4. S.C. Textor and C.S. Wilcox, Renal artery stenosis: A common, treatable cause of renal failure?. Annu Rev Med 52 (2001), pp. 421–442.
5. A. Vashist, E.N. Heller, E.J. Brown et al. , Renal artery stenosis: A cardiovascular perspective. Am Heart J 143 (2002), pp. 559–564.
6. P.-F. Plouin, P. Rossignol and G. Bobrie, Atherosclerotic renal artery stenosis: To treat conservatively, to dilate, to stent, or to operate?. J Am Soc Nephrol 12 (2001), pp. 2190–2196.
7. R.D. Safian, Atherosclerotic renal artery stenosis. Curr Treat Options Cardiovasc Med 5 (2003), pp. 91–101.
8. C.J. White, Renal artery revascularization: Percutaneous stent placement is the standard of practice. Vasc Med 7 (2002), pp. 3–4.
9. P.J. Mackrell, E.M. Langan, T.M. Sullivan et al. , Management of renal artery stenosis: Effects of a shift from surgical to percutaneous therapy on indications and outcomes. Ann Vasc Surg 17 (2003), pp. 54–59.
10. M. Birrer, D.D. Do, F. Mahler et al. , Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: A prospective follow-up study. Eur J Vasc Endovasc Surg 23 (2002), pp. 146–152.
11. C. Mounier-Vehier, C. Lions, O. Jaboureck et al. , Parenchymal consequences of fibromuscular dysplasia renal artery stenosis. Am J Kidney Dis 40 (2002), pp. 1138–1145.
12. C. Mounier-Vehier, S. Haulon , P. Devos et al. , Renal atrophy outcome after revascularization in fibromuscular dysplasia disease. J Endovasc Ther 9 (2002), pp. 605–613.
13. B.A. Greco and J.A. Breyer, The natural history of renal artery stenosis: Who should be evaluated for suspected ischemic nephropathy?. Semin Nephrol 16 (1996), pp. 2–11.
14. S. Kuroda, N. Nishida , T. Uzu et al. , Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 31 (2000), pp. 61–65.
15. C.M. Gross, J. Kramer, J. Waigand et al. , Renovascular illness: Prevalence and therapy in patients with coronary heart disease. Z Kardiol 89 (2000), pp. 747–753.
16. J.W. Olin, M. Melia, J.R. Young et al. , Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88 (1990), pp. 46N–51N.
17. N.T. Caps, C. Perissinotto, R.E. Zierler et al. , Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98 (1998), pp. 2866–2872.
18. J.J. Crowley, R.M. Santos, R.H. Peter et al. , Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 136 (1998), pp. 913–918.
19. R.A. Fatica, F.K. Port and E.W. Young, Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States . Am J Kidney Dis 37 (2001), pp. 1184–1190.
20. H. Tunstall-Pedoe, D. Vanuzzo, M. Hobbs et al. , Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 3555 (2000), pp. 688–700.
21. W.D. Hall and B. Olutade, Renal considerations in geriatric patients with heart disease. Am J Geriatr Cardiol 4 (1995), pp. 49–52.
22. I.A. Alhaddad, S. Blum, E.N. Heller et al. , Renal artery stenosis in minority patients undergoing diagnostic cardiac catheterization: Prevalence and risk factors. J Cardiovasc Pharmacol Ther 6 (2001), pp. 147–153.
23. P.J. Conlon, K. Athirakul, E. Kovalik et al. , Survival in renal vascular disease. J Am Soc Nephrol 9 (1998), pp. 252–256.
24. P.J. Conlon, M.A. Little, K. Pieper et al. , Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 60 (2001), pp. 1490–1497.
25. C.G. Missouris , A.-M. Belli and G.A. MacGregor, “Apparent” heart failure: A syndrome caused by renal artery stenosis. Heart 83 (2000), pp. 152–155.
26. M.J. Bloch, D.W. Trost, T.G. Pickering et al. , Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens 12 (1999), pp. 1–7.
27. S. Ziakka, A.M. Belli, T.K. Kong et al. , Percutaneous transluminal renal artery angioplasty: Who benefits most?. Int J Clin Pract 56 (2002), pp. 649–654.
28. P. Simon, S. Benarbia , C. Charasse et al. , [Ischemic renal diseases have become the most frequent causes of end stage renal disease in the elderly]. Arch Mal Coeur Vaiss 91 (1998), pp. 1065–1068.
29. R.A. Preston and M. Epstein, Ischemic renal disease: An emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 15 (1997), pp. 1365–1377.
30. D.L. Cohen, R.R. Townsend, S. Kobrin et al. , Dramatic recovery of renal function after 6 months of dialysis dependence following surgical correction of total renal artery occlusion in a solitary functioning kidney. Am J Kidney Dis 37 (2001), p. E7.
31. A. Bracco, S.A. Garrido and J. Valdecantos, Kidney revascularization and function recovery in patients in dialysis. Medicina 58 (1998), pp. 747–754.
32. J. Main, How important is atheromatous renal artery stenosis as a cause of end-stage renal disease?. Semin Dial 14 (2001), pp. 143–145.
33. J.S. Kooner, W.S. Peart and C.J. Mathias, The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man. Clin Auton Res 1 (1991), pp. 195–204.
34. M.J. Petersson, B. Rundqvist, M. Johansson et al. , Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 20 (2002), pp. 1181–1187.
35. T.K. Wierema, A.J. Houben, A.A. Kroon et al. , Nitric oxide dependence of renal blood flow in patients with renal artery stenosis. J Am Soc Nephrol 12 (2001), pp. 1836–1843.
36. D.H. Sigmon and W.H. Beierwaltes, Degree of renal artery stenosis alters nitric oxide regulation of renal hemodynamics. J Am Soc Nephrol 5 (2001), pp. 1836–1843.
37. K.E. Teunissen, C.T. Postma, B.C. van Jaarsveld et al. , Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty. J Hypertens 15 (1997), pp. 1791–1796.
38. E. Poch, W. Jimenez, F. Feu et al. , Increased plasma endothelin concentration in atherosclerotic renovascular hypertension. Nephron 71 (1995), pp. 291–296.
39. L.O. Lerman, K.A. Nath, M. Rodriguez-Porcel et al. , Increased oxidative stress in experimental renovascular hypertension. Hypertension 37 (2001), pp. 541–546.
40. D. Harrison, K.K. Griendling, U. Landmesser et al. , Role of oxidative stress in atherosclerosis. Am J Cardiol 91 (2003), pp. 7A–11A.
41. Y. Higashi, S. Sasaki, K. Nakagawa et al. , Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346 (2002), pp. 1954–1962.
42. P. Krijnen, B.C.V. Jaarsveld, E.W. Steyerberg et al. , A clinical prediction rule for renal artery stenosis. Ann Intern Med 129 (1998), pp. 705–711.
43. G.B. Vasbinder, P.J. Nelemans, A.G. Kessels et al. , Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A meta-analysis. Ann Intern Med 135 (2001), pp. 401–411.
44. B.C. van Jaarsveld, P. Krijnen, F.H. Derkx et al. , The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med 157 (1997), pp. 1226–1234.
45. J.H. Clorius, J. Allenberg, T. Hupp et al. , Predictive value of exercise renography for presurgical evaluation of nephrogenic hypertension. Hypertension 10 (1987), pp. 280–286.
46. K.T. Tan, E.J. van Beek, P.W. Brown et al. , Magnetic resonance angiography for the diagnosis of renal artery stenosis: A meta-analysis. Clin Radiol 57 (2002), pp. 617–624.
47. T.K. Mittal, C. Evans, T. Perkins et al. , Renal arteriography using gadolinium enhanced 3D MR angiographyclinical experience with the technique, its limitations and pitfalls. Br J Radiol 74 (2001), pp. 495–502.
48. S.O. Schoenberg, M. Bock, S. Aumann et al. , Quantitative recording of renal function with magnetic resonance tomography. Radiologe 40 (2000), pp. 925–937.
49. S.O. Schoenberg, M.V. Knopp, F. Londy et al. , Morphologic and functional magnetic resonance imaging of renal artery stenosis: A multireader tricenter study. J Am Soc Nephrol 13 (2002), pp. 158–169.
50. B. Krumme, U. Blum, E. Schwertfeger et al. , Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kidney Int 50 (1996), pp. 1288–1292.
51. T. Zeller, U. Frank, M. Spath et al. , Color duplex ultrasound imaging of renal arteries and detection of hemodynamically relevant renal artery stenoses. Ultraschall Med 22 (2001), pp. 116–121.
52. T. Zeller, U. Frank, C. Muller et al. , Duplex ultrasound for follow-up examination after stent-angioplasty of ostial renal artery stenoses. Ultraschall Med 23 (2002), pp. 315–319.
53. M.J. Sharafuddin, C.A. Raboi, M. Abu-Yousef et al. , Renal artery stenosis: Duplex US after angioplasty and stent placement. Radiology 220 (2001), pp. 168–173.
54. J. Radermacher, A. Chavan, J. Bleck et al. , Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344 (2001), pp. 410–417.
55. R. Solomon, C. Werner, D. Mann et al. , Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331 (1994), pp. 1416–1420.
56. D.J. Eschelman, K.L. Sullivan, J. Bonn et al. , Carbon dioxide as a contrast agent to guide vascular interventional procedures. AJR Am J Roentgenol 171 (1998), pp. 1265–1270.
57. G. Ailawadi, J.C. Stanley, D.M. Williams et al. , Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 37 (2003), pp. 346–352.
58. F. Scolari, R. Tardanico, R. Zani et al. , Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 36 (2000), pp. 1089–1109.
59. D. Weber-Mzell, P. Kotanko, M. Schumacher et al. , Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J 23 (2002), pp. 1684–1691.
60. T. Yamashita, F. Ito, N. Iwakiri et al. , Prevalence and predictors of renal artery stenosis in patients undergoing cardiac catheterization. Hypertens Res 25 (2002), pp. 553–557.
61. R.G. Cigarroa, R.A. Lange, R.H. Williams et al. , Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86 (1989), pp. 649–652.
62. M. Böhm, R. Fries, B. Hennen et al. , Indikationen zur renovasographie und zur perkutanen transluminalen nierenarteriendilatation. Dtsch Med Wochenschr 128 (2003), pp. 150–156.
63. J.N. Beattie, S.S. Soman, K.R. Sandberg et al. , Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37 (2001), pp. 1191–1200.
64. A. Weerasinghe, P. Hornick, P. Smith et al. , Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction. J Thorac Cardiovasc Surg 121 (2001), pp. 1083–1089.
65. L. Gruberg, R. Mehran, G. Dangas et al. , Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52 (2001), pp. 409–416.
66. M.H. Rubenstein, L.C. Harrell, B.V. Sheynberg et al. , Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 (2000), pp. 2966–2972.
67. M. Moscucci, E. Kline-Rogers, D. Share et al. , Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation 104 (2001), pp. 263–268.
68. B.C. van Jaarsveld, P. Krijnen, H. Pieterman et al. , The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med 342 (2000), pp. 1007–1014.
69. S.C. Textor, A.C. Nock, D.R. Steinmuller et al. , Renal failure limiting antihypertensive therapy as an indication for renal revascularization. Arch Intern Med 143 (1983), pp. 2208–2211.
70. P.J.G. van den Ven, J.J. Beutler, R. Kaatee et al. , Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int 53 (1998), pp. 986–993.
71. N.K. Hollenberg, Medical therapy of renovascular hypertension: Efficacy and safety of captopril in 269 patients. Cardiovasc Rev Rep 4 (1983), pp. 852–876.
72. B. Jackson, L. Franze, E. Sumithra et al. , Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. J Lab Clin Med 115 (1990), pp. 21–27.
73. P. Minuz, P. Patrignani, S. Gaino et al. , Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106 (2002), pp. 2800–2805.
74. T.K. Khong, C.G. Missouris, A.M. Belli et al. , Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens 15 (2001), pp. 431–433.
75. J.M. Alcazar, R. Marin, F. Gomez-Campdera et al. , Clinical characteristics of ischaemic renal disease. Nephrol Dial Transplant 16 suppl 1 (2001), pp. 74–77.
76. T.G. Pickering, T.A. Sos and J.H. Laragh, Role of balloon dilatation in the treatment of renovascular hypertension. Am J Med 77 (1984), pp. 61–66.
77. K.P. Cicuto, G.K. McLean, J.A. Oleaga et al. , Renal artery stenosis: Anatomic classification for percutaneous transluminal angioplasty. AJR Am J Roentgenol 137 (1981), pp. 599–601.
78. U. Blum, B. Krumme, P. Flugel et al. , Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 336 (1997), pp. 459–465.
79. D. Bergqvist, K. Jonsson and H. Weibull, Complications after percutaneous transluminal angioplasty of peripheral and renal arteries. Acta Radiol 28 (1987), pp. 3–12.
80. G. Geroulakos, C. Missouris, A. Mitchell et al. , Endovascular treatment of renal artery stenosis. J Endovasc Ther 8 (2001), pp. 177–185.
81. K.R. Tuttle and R.D. Raabe, Endovascular stents for renal artery revascularization. Curr Opin Nephrol Hypertens 7 (1998), pp. 695–701.
82. R.J. Lederman, F.O. Mendelsohn, R. Santos et al. , Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J 142 (2001), pp. 314–323.
83. A. Chatziioannou, D. Mourikis, B. Agroyannis et al. , Renal artery stenting for renal insufficiency in solitary kidney in 26 patients. Eur J Vasc Endovasc Surg 23 (2002), pp. 49–54.
84. R. Cioni, C. Vignali, P. Petruzzi et al. , Renal artery stenting in patients with a solitary functioning kidney. Cardiovasc Interv Radiol 24 (2001), pp. 372–377.
85. R. Andrews, K.S. Nayak, S. Krishnan et al. , Percutaneous transluminal renal angioplasty with stent for treatment of transplant renal artery stenosis: A case report. Transplant Proc 35 (2003), pp. 304–306.
86. S.J. Fu, Q. Yuan and L.X. Yu, Retrospective study of 10 cases of transplant renal artery stenosis. Di Yi Jun Yi Da Xue Xue Bao 23 (2003), pp. 175–176.
87. M. Henry, C. Klonaris, I. Henry et al. , Protected renal stenting with the PercuSurge GuardWire device: A pilot study. J Endovasc Ther 8 (2001), pp. 227–237.
88. E. Yutan, D.J. Glickerman, M.T. Caps et al. , Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg 34 (2001), pp. 685–693.
89. B. Symonides, J. Chodakowska, A. Januszewicz et al. , Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Press 8 (1999), pp. 141–150.
90. L. Bax, W.P. Mali, P.J. Van De Ven et al. , Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 13 (2002), pp. 1219–1224.
91. M.S. Aslam, J. Balasubramanian and B.R. Greenspahn, Brachytherapy for renal artery in-stent restenosis. Catheter Cardiovasc Interv 58 (2003), pp. 151–154.
92. C.G. Isles, S. Robertson and D. Hill, Management of renovascular disease: A review of renal artery stenting in ten studies. QJM 92 (1999), pp. 159–167.
93. A.J. Nordmann, K. Woo, R. Parkes et al. , Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 114 (2003), pp. 44–50.
94. N.J. Ives, K. Wheatley, R.L. Stowe et al. , Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials. Nephrol Dial Transplant 18 (2003), pp. 298–304.
95. J.H.V. Bockel, R.V. Schilfgaarde, W. Felthuis et al. , Surgical treatment of renal vascular hypertension caused by arteriosclerosis: Influence of preoperative factors on blood pressure control early and late after reconstructive surgery. Surgery 101 (1987), pp. 698–705.
96. J. Webster, F. Marshall, M. Abdalla et al. , Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 12 (1998), pp. 329–335.
97. P.F. Plouin, G. Chatellier, B. Darne et al. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group, Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Hypertension 31 (1998), pp. 823–829.
98. J.P. Middleton, Ischemic disease of the kidney: How and why to consider revascularization. J Nephrol 11 (1998), pp. 123–136.
99. V. Chabova, A. Schirger, A.W. Stanson et al. , Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc 75 (2000), pp. 435–436.
100. D.W. Cockcroft and M.H. Gault, Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976), pp. 31–41.
101. C.R. Rees, J.C. Palmaz, G.J. Becker et al. , Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: Preliminary report of a multicenter study. Radiology 181 (1991), pp. 507–514.
102. J. Radermacher, R. Weinkove and H. Haller, Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease. Curr Opin Nephrol Hypertens 10 (2001), pp. 799–805.
103. P.S. Watson, P. Hadjipetrou, S.V. Cox et al. , Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 102 (2000), pp. 1671–1677.
104. J.J. Beutler, J.M.A. van Ampting, P.J.G. van den Ven et al. , Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 12 (2001), pp. 1475–1481.
105. P.J. Nelemans, A.G. Kessels, P.D. Leeuw et al. , The cost-effectiveness of the diagnosis of renal artery stenosis. Eur J Radiol 27 (1998), pp. 95–107.
106. O. Hoffman, T. Carreres, M.R. Sapoval et al. , Ostial renal artery stenosis angioplasty: Immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol 9 (1998), pp. 65–73.
107. G. Dorros, M. Jaff, L. Mathiak et al. , Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 55 (2002), pp. 182–188.
108. V. Perkovic, K.R. Thomson, P.J. Mitchell et al. , Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes. Australas Radiol 45 (2001), pp. 438–443.
109. G. Dangas, J.R. Laird, Jr, R. Mehran et al. , Intravascular ultrasound-guided renal artery stenting. J Endovasc Ther 8 (2001), pp. 238–247.
110. R.L. Bush, S. Najibi, M.J. MacDonald et al. , Endovascular revascularization of renal artery stenosis: Technical and clinical results. J Vasc Surg 33 (2001), pp. 1041–1049.
111. M.F. Giroux, G. Soulez, E. Therasse et al. , Percutaneous revascularization of the renal arteries: Predictors of outcome. J Vasc Interv Radiol 11 (2000), pp. 713–720.
112. M.W. Burket, C.J. Cooper, D.J. Kennedy et al. , Renal artery angioplasty and stent placement: Predictors of a favorable outcome. Am Heart J 139 (2000), pp. 64–71.
113. J.H. Rundback, T. Manoni, G.N. Rozenblit et al. , Balloon angioplasty or stent placement in patients with azotemic renovascular disease: A retrospective comparison of clinical outcomes. Heart Dis 1 (1999), pp. 121–125.
115. A. Lovaria, A. Nicolini, D. Meregaglia et al. , Interventional radiology in the treatment of renal artery stenosis. Ann Urol ( Paris ) 33 (1999), pp. 146–155.
116. D. Paulsen, N.E. Klow, B. Rogstad et al. , Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease. Nephrol Dial Transplant 14 (1999), pp. 1454–1461.
117. J.A. Rodriguez-Lopez, A. Werner, L.I. Ray et al. , Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Surg 29 (1999), pp. 617–624.
118. M. Henry, M. Amor, I. Henry et al. , Stents in the treatment of renal artery stenosis: Long-term follow-up. J Endovasc Surg 6 (1999), pp. 42–51.
119. N.E. Klow, D. Paulsen, K. Vatne et al. , Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients. Acta Radiol 39 (1998), pp. 594